|
Post by esstan2001 on Oct 28, 2016 8:20:40 GMT -5
The #'s posted havent been posted here yet, where are you getting this from. Yes, they were. By ripano in the same place they usually first appear. See the "Symphony Script Data" thread. Every so often, the data is very 'anomalous'. Before anyone jumps out their first story window, how certain are we that this is not one of those times?
|
|
|
Post by esstan2001 on Oct 20, 2016 11:26:02 GMT -5
I filled out the online form on Dr. Oz's website and recommended Laura Kronen as a guest. I reached out to her and she thought it was a good idea. I suggest others do the same. If they receive enough demand it might actually happen. Link to form: www.doctoroz.com/guest-plug/do-you-want-be-guest-dr-oz-showHere's what I sent to the land of Oz- There is a new inhaled insulin named Afrezza that was approved in 2014 by the FDA for both Type 1 & Type 2 patients, from a small company named Mannkind which was started by serial biotech entrepreneur Alfred Mann (Founder of Mini-Med, and inventor of their insulin pump which is now owned by St. Jude Medical). What is unique about this treatment is that it is ultra rapid acting due to being in mono-meric form, and so induces hepatic glucose shutdown at the liver, making dosing accuracy less critical, and it exits the body between 2-3 hrs, significantly reducing the chance of hypoglycemic events. Patients consistently are achieving lifetime best non-diabetic A1C readings, and real time blood glucose concentration levels as evidenced by patient CGM's. Laura Kroonen is one such patient; I suggest that you invite her along with a panel of Afrezza patients for an entire show to expose the positive impact this is having on the diabetic community. Here are some links to Afrezza patients with what they say, experience, and feel on social media: ... about 10 twitter accounts of our favorite users...
|
|
|
Post by esstan2001 on Oct 19, 2016 14:18:57 GMT -5
This appears to be the start of a change in the momentum regarding Marketing- WE have Laura, Adam Lasher, AfrezzaUser, & others that can now ramp up appearances in media to spread the word to consumers. Sure we need people like this to get interviewed on Dr. Oz, Dr Gupta, etc and I hope that is the next step that is getting worked... Start the buzz campaign now that a fair number of docs have been exposed. These patients (without 'opinionating' by docs) are going to be our awesome advocates. These people are nobodies. The only became somebodies when investors needed something positive to grasp on to. No one is buying Afrezza based on anything they have to say. Its time to come back down to earth So are some of the people on this Earthly message board.
|
|
|
Post by esstan2001 on Oct 19, 2016 13:50:41 GMT -5
This appears to be the start of a change in the momentum regarding Marketing- WE have Laura, Adam Lasher, AfrezzaUser, & others that can now ramp up appearances in media to spread the word to consumers. Sure we need people like this to get interviewed on Dr. Oz, Dr Gupta, etc and I hope that is the next step that is getting worked...
Start the buzz campaign now that a fair number of docs have been exposed. These patients (without 'opinionating' by docs) are going to be our awesome advocates.
|
|
|
Post by esstan2001 on Oct 18, 2016 8:44:01 GMT -5
So then you are fully discounting any possibility of: -RLS milestone payment -Inhaled epi partner deal -ROW Afrezza partnership -Additional capital infusions from any financing deals OK then. You've made clear your stance. No, I just don't think a milestone payment of $5,000,000 - $25,000,000 (which is where I think it will be) is enough of a runway to increase scripts enough to get to break even. Epi partner? Not anytime soon and without afrezza being successful, if they do get a deal it won't include much upfront cash. Are you dumping your capital into the company right now? Look, afrezza seems good but it costs us $10,000,000 a month right now. IMO, any financing deal is going to be incredibly painful but necessary to keep the lights on. And until afrezza starts selling, it will continue to happen. Really can not disagree with what you say, but glass half full, some combo of 2-3 of the above can buy them time to get results on scripts- they are actively trying to turn endos and this obviously takes time. Yes it is a race to beat the clock, and time waits for no one; But this game is not decided yet.
|
|
|
Post by esstan2001 on Oct 17, 2016 20:17:19 GMT -5
There are certainly valid reasons for shareholders getting 'spooked'. But there is also every reason to believe that in this environment the shorts would ply their wares in parallel to magnify the effect. That is in their best interest. Exactly. I'd think about shorting it! I don't see it going up, why would it? The only thing I see that would make it go up is a buyout - but I think we are past that. Crazy to short something with confidence after losing $65,000? I don't think so. But then again, I'm not touching this stock ever again on either side. Just enjoy watching it without any feeling one way or the other So then you are fully discounting any possibility of: -RLS milestone payment -Inhaled epi partner deal -ROW Afrezza partnership -Additional capital infusions from any financing deals OK then. You've made clear your stance.
|
|
|
Post by esstan2001 on Oct 17, 2016 15:57:48 GMT -5
So, we hang on for now and wait for the Ship of State to make its long turn back the other way. It’s hard when the SP is under such assault as it is again today, but we will prevail. This is a war we’re in and Winston Churchill said it best: "I have nothing to offer but blood, toil, tears and sweat.” I for one have tightened my chin strap and remain resolute. Aloha. So you think that this is all short selling? No one is getting spooked and selling their shares? There are certainly valid reasons for shareholders getting 'spooked'. But there is also every reason to believe that in this environment the shorts would ply their wares in parallel to magnify the effect. That is in their best interest.
|
|
|
Cash
Oct 17, 2016 14:44:29 GMT -5
prvs likes this
Post by esstan2001 on Oct 17, 2016 14:44:29 GMT -5
Guess we are all banking on a material RLS milestone.
|
|
|
Post by esstan2001 on Oct 16, 2016 9:04:29 GMT -5
They really should have stuck a baseball glove on Outsulin's hand, and given him a bat to carry. But I suppose the cash situation didn't allow for any changes to previously done Outsulin artwork. Put the bat in Insulin's hands, hitting one where Outsulin catches it, and the umpire yells, 'YOUR OUT !!!'
|
|
|
Post by esstan2001 on Oct 4, 2016 11:04:22 GMT -5
I suspect that Pfeffer and Thompson (maybe even Kresa?) were in a conference Room at 55 Corporate Dr, Bridgewater, NJ 08807 and that "raising money" would be one way to describe the meetings. Ah Ha...
|
|
|
Post by esstan2001 on Sept 23, 2016 6:45:57 GMT -5
|
|
|
Post by esstan2001 on Sept 22, 2016 7:35:40 GMT -5
Is there a penalty for not complying with the stipulated 4 day public announcement requirement? If so... management dropped the ball on this one. I assume this is a relatively minor thing- but how do you let a simple notification like this just slip through the crack, only to have to embarrass yourself later with a worse notification including admission? Rose? Matt? Come on. This can't endear you to the investment community. Go find that rabbit in that hat already.
|
|
|
Post by esstan2001 on Sept 9, 2016 7:28:02 GMT -5
I think it's a great NPR story as is, not about MNKD, but about Afrezza - almost exclusively about Afrezza. We got guys like Sam and Eric who could be interviewed in person while eating a high carb meal and showing results on a CGM. For an NPR, at this stage, the story is noteworthy for what Afrezza offers so many people. If MNKD makes it in the end, then a piece featuring MNKD, but by that time, I won't care. I just want diabetics to know this stuff exists, and fellow diabetics think the world if it. NPR and APM aren't in the drug promotion business. To be fair and objective they'd have to balance Sam and Eric with people who had problems with Afrezza and stopped taking it -- and the dismal refill numbers show that there are a lot of such people. They'd also have to interview both doctors who are enthusiastic about Afrezza and docs who think it has yet to prove itself or is too risky. As an investor I desperately want Afrezza to succeed, but as a journalist I don't see much of a story....yet. Baba- these damn New Yorkers... always having to be such realists. Could tell you lost your cynicism for a moment, and were actually having happy thoughts. Lefty- have to be such a Killjoy? (Apt name for someone that takes people ['s happiness] out...)
|
|
|
Post by esstan2001 on Sept 8, 2016 15:47:09 GMT -5
baba - mnholdem's option diagonal explanation makes good sense from the persective of the LEAP buyer... On another note, was thinking about you a week ago after I power washed my Hobie 14 out from under 12 years of muck (all it needed was a few bungee return lines replaced!) so I could take my 11 yr. old son out for the experience... We were soooo close to flying a hull- In my best Maxwell Smart... "Would you believe: esstan, very cool! Don't tell me you remember my story about pitch-poling the Hobie 16 in Mission Bay, San Diego (did I tell that here?). Catamarans are so much fun! I think it was in a PM, and I do not recall anything about pitch-poling it... but yes! it is always fun to get wet, no matter what. Will be making an effort to get out a few more times this year (Peconic Bay, between the forks of Long Island, and hoping for more knots of wind than the low teens) so I can pretend that I am not getting old yet.
|
|
|
Post by esstan2001 on Sept 8, 2016 12:28:59 GMT -5
baba - mnholdem's option diagonal explanation makes good sense from the persective of the LEAP buyer... On another note, was thinking about you a week ago after I power washed my Hobie 14 out from under 12 years of muck (all it needed was a few bungee return lines replaced!) so I could take my 11 yr. old son out for the experience... We were soooo close to flying a hull- In my best Maxwell Smart... "Would you believe:
|
|